Induced pluripotent stem cell derived liver model for the study of PNPLA3-induced non-alcoholic fatty liver disease

被引：0
|
作者：
Tilson, S. [1 ,2 ,3 ]
Morell, C. M. [2 ]
Lenaerts, A-S. [2 ]
Liang, T. J. [3 ]
Vallier, L. [1 ,2 ]
机构：
[1] Wellcome Trust Sanger Insitute, Cellular Genet, Hinxton, England
[2] Wellcome Trust Med Res Council Stem Cell Inst, Surg, Cambridge, England
[3] NIDDK, Liver Dis Branch, Bethesda, MD 20892 USA
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)30400-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PS-164
引用
收藏
页码：S90 / S91
页数：2
相关论文
共 50 条
  • [1] INDUCED PLURIPOTENT STEM CELL DERIVED LIVER MODEL FOR THE STUDY OF PNPLA3-INDUCED NON-ALCOHOLIC FATTY LIVER DISEASE
    Tilson, Samantha
    Morell, Carola
    Lenaerts, An-Sofie
    Jenkins, Benjamin
    Koulman, Albert
    Liang, T. Jake
    Vallier, Ludovic
    [J]. HEPATOLOGY, 2019, 70 : 1287A - 1287A
  • [2] Modelling non-alcoholic fatty liver disease using human induced pluripotent stem cells
    Morell, C. M.
    Tilson, S.
    Perrin, M.
    Gieseck, T.
    Geti, I.
    Rimland, C.
    Sampaziotis, F.
    Vallier, L.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S29 - S30
  • [3] Human induced pluripotent stem cell-derived mesenchymal stem cells ameliorates mitochondrial oxidative dysfunction in non-alcoholic fatty liver disease
    Park, Min Kyung
    Lee, Yun Bin
    Jung, Se-Mi
    Kwon, Yoo-Wook
    Yoon, Jung-Hwan
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S667 - S667
  • [4] Generation of a TALEN-mediated stem cell model to study non-alcoholic fatty liver disease associated with a PNPLA3 polymorphism
    Goyal, Nidhi
    Ordonez, Maria P.
    Goldstein, Lawrence S.
    [J]. HEPATOLOGY, 2014, 60 : 741A - 741A
  • [5] Hepatic Chemerin is Induced in Non-Alcoholic Fatty Liver Disease
    Buechler, Christa
    Wanninger, Josef
    Bauer, Sabrina
    Eisinger, Kristina
    Schacherer, Doris
    Hellerbrand, Claus
    Weiss, Thomas S.
    Schaffler, Andreas
    [J]. DIABETES, 2012, 61 : A691 - A692
  • [6] PNPLA3 as a Genetic Determinant of Risk for Progression and Outcomes in Non-Alcoholic Fatty Liver Disease and Alcoholic Liver Disease
    Arora, Sumant S.
    Seay, Toni
    Crowley, Michael
    Edberg, Jeff
    Singal, Ashwani K.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S555 - S555
  • [7] Hepatic copper and PNPLA3 in patients with non-alcoholic fatty liver disease
    Staettermayer, Albert
    Traussnigg, Stefan
    Aigner, Elmar
    Kienbacher, Christian
    Steindl-Munda, Petra E.
    Datz, Christian
    Wrba, Fritz
    Trauner, Michael
    Ferenci, Peter
    [J]. HEPATOLOGY, 2014, 60 : 609A - 609A
  • [8] PNPLA3 GENOTYPE: RELATIONSHIP TO SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE
    Al-Serri, Ahmad
    Day, Christopher P.
    Daly, Ann K.
    [J]. HEPATOLOGY, 2009, 50 (04) : 1167A - 1168A
  • [9] ACTIVITYOF COAGULATION FACTORS IX ANDXIII AND FIBRINOGEN ARE INCREASED IN "OBESE NON-ALCOHOLIC FATTY LIVER DISEASE" BUT NOT IN "PNPLA3 NON-ALCOHOLIC FATTY LIVER DISEASE"
    Lallukka, S.
    Orho-Melander, M.
    Lundbom, N.
    Olkkonen, V. M.
    Yki-Jarvinen, H.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S499 - S499
  • [10] Lipid Biomarkers in Liver Cancer Derived from Diet-induced Non-alcoholic Fatty Liver Disease
    Rivera, Maria
    Puri, Puneet
    Pacana, Tommy
    Patel, Vaishali
    Katainen, Riikka
    Vihervaara, Terhi
    Mirshahi, Faridoddin
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2013, 58 : 548A - 548A
12345